Diagnostic accuracy of oncologic ultra-low-dose FDG-PET imaging: a pilot study
Conclusions: This small pilot study suggests that, with use of a high-sensitivity commercial PET system, ultra-low-dose FDG (equivalent to 2-4 mCi / 74-148 MBq injected FDG dose) PET may be feasible for oncologic applications, without loss of diagnostic accuracy. These results will be further investigated in a larger study to confirm validity.
Source: Journal of Nuclear Medicine - Category: Nuclear Medicine Authors: Niederkohr, R., Hamill, J., Jones, J. Tags: Data Analysis & amp; Management (Poster Session) Source Type: research
More News: Breast Cancer | Cancer | Cancer & Oncology | Lung Cancer | Lymphoma | Non-Hodgkin's Lymphoma | Non-Small Cell Lung Cancer | Nuclear Medicine | PET Scan | Study